Menu

A Differentiated Cannabis Investment Opportunity

login icon

Danny Brody

Emblem proved itself to be one of the most successful IPOs in 2016 and during this engaging discussion, you will learn how it is positioned to capitalize on the burgeoning Canadian cannabis industry. Emblem has been able to differentiate itself from other Canadian licensed medical cannabis producers through its attractive business model, proven management team, and high-quality products. Danny Brody, Emblem's director of investor relations, will provide a thorough breakdown of its unique value proposition that will make this a presentation you do not want to miss!